Abstract:Fubei Nan, Qingxin Tian, Shuangdong Chen Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China Correspondence: Shuangdong Chen, Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang Street, Ouhai District, Wenzhou, Zhejiang, 325035, People's Republic of China, Tel +8613732058295, Email Background: Treating inflammatory pain (IP) continues to pose clinical challenge, because of the lack of effective pharmacological interventions. Microglial polarization serves as pivotal determinant in IP progress. Obacunone (OB), a low-molecular-weight compound with a diverse array of biological functions, having reported as an activator of nuclear factor E2-related factor 2 (Nrf2), exhibits anti-inflammatory property. However, it remains uncertain whether OB can alleviate IP by facilitating the transition of microglial polarization from the M1 to M2 state through modulating Nrf2/ heme oxygenase-1 (HO-1) pathway. Methods: We induced an mice IP model by subcutaneously administering Complete Freund's Adjuvant (CFA) into the hind paw. Paw withdrawal latency (PWL) in seconds (s) and paw withdrawal frequency (PWF) were employed to evaluate the establishment of the IP model, while a caliper was used to measure the maximal dorsoventral thickness of the mice paw. Nerve injury was assessed by Hematoxylin-Eosin (HE) Staining. Western blot and got conducted for detection of M1/M2 microglial polarization markers, Nrf2 and HO-1 in spinal cord tissues respectively. Results: In comparison to the control cohort, PWF, M1 phenotype marker iNOS, CD86, paw thickness increased significantly within CFA cohort, while PWL, M2 phenotype marker Arg-1, interleukin-10 (IL-10) decreased in the CFA group. In comparison to model cohort, OB treatment decreased PWF, paw thickness, M1 phenotype marker iNOS, CD86 significantly, while PWL, M2 phenotype marker Arg-1, IL-10, Nrf2, HO-1 increased significantly. The morphological injuries of sciatic nerve in CFA mice were obviously improved by OB treatment. OB inhibited the release of M1-related IL-1β, CXCL1 but promoted M2-related TGF-β, IL-10 in serum in CFA mice. The intervention of the Nrf2 inhibitor ML385 mitigated analgesic effect of OB. Conclusion: We demonstrate that OB is able to attenuate inflammatory pain via promoting microglia polarization from M1 to M2 and enhancing Nrf2/HO-1 signal. OB treatment may be a potential alternative agent in the treatment of IP. Keywords: inflammatory pain, obacunone, Nrf2, HO-1 Pain serves as a sentinel, alerting us to potential or actual tissue damage and triggering an adaptive protective response. 1 When peripheral tissues are subjected to noxious stimuli, it leads to pain hypersensitivity through primary sensory neurons peripheral sensitization. 2,3 CFA activates cellular immune responses and boosts the generation of immunoglobulins, thereby acting as an immune enhancer. 4,5 CFA-induced responses above result in inflammation in tissue within injected area, as well as cytokines release. 6 Microglia are macrophage-like cells in central nervous system (CNS), holding homeostasis within brain, as well as spinal cord. A growing body of evidence from previous research indicates that, microglia serve as pivotal determinant within pain pathogenesis. 7–9 Evidence supported, microglia/macrophages exhibit high plasticity and adapt their phenotypes in response to diverse microenvironmental cues, including proinflammatory and anti-inflammatory signals. 10 The pro-inflammatory M1-like phenotype, typified by specific biomarker expression, inclusive of nitric oxide synthase (iNOS) and CD86, tends to release harmful mediators. In contrast, the anti-inflammatory M2-like phenotype, defined by molecular signatures like CD206 and interleukin-10 (IL-10), produces beneficial mediators. 11 Multiple studies have demonstrated that encouraging a shift in microglia from the M1 to the M2 state could hold promise as a therapy for inflammatory pain (IP) treatment. 12–14 Nuclear factor E2-related factor 2 (Nrf2) has been commonly recognized as the key transcription factor that regulates inflammation and oxidative stress in pain. 15 Nrf2 resides in the cytoplasm controlled within normal conditions, where it is retained by associating with Kelch-like ECH-associated protein 1 (Keap-1). However, in response to harmful insults, it dissociates from Keap-1, subsequently translocating to the nucleus, prompting the transcription of enzymes being antioxidant and anti-inflammatory, including heme oxygenase-1 (HO-1), thus modulating the inflammatory process. 16 Previous studies have affirmed anti-i -Abstract Truncated-

Effects of treatment with a carbon monoxide donor and an activator of heme oxygenase 1 on the nociceptive, apoptotic and/or oxidative alterations induced by persistent inflammatory pain in the central nervous system of mice

Exogenous Administration of Carbon Monoxide Alleviates Neuron Death after Spinal Cord Injury via Inflammasome Regulation

The Beneficial Effects of Heme Oxygenase 1 and Hydrogen Sulfide Activation in the Management of Neuropathic Pain, Anxiety- and Depressive-like Effects of Paclitaxel in Mice

HO-1 IN SPINAL CORD MEDIATES NEUROPATHIC PAIN IN RATS

Effects of heme oxygenase 1 in the molecular changes and neuropathy associated with type 2 diabetes in mice

Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain

The Combination of Molecular Hydrogen and Heme Oxygenase 1 Effectively Inhibits Neuropathy Caused by Paclitaxel in Mice

Post-treatment with maropitant reduces oxidative stress, endoplasmic reticulum stress and neuroinflammation on peripheral nerve injury in rats

Carbon Monoxide-Releasing Molecule-2 Inhibits Connexin 43-Hemichannel Activity in Spinal Cord Astrocytes to Attenuate Neuropathic Pain

Carbon Monoxide-Based Therapy Ameliorates Acute Pancreatitis Via TLR4 Inhibition.

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway

Effects of Cyclooxygenase 2 Inhibitor on Growth-Associated Protein 43 and Nerve Growth Factor Expression in Dorsal Root Ganglion During Neuropathic Pain Development

Changes of expressions of three cyclooxygenase isoforms in brain of mice with inflammatory pain and the analgesic effects of different selective cyclooxygenase inhibitors

The peripheral administration of a nitric oxide donor potentiates the local antinociceptive effects of a DOR agonist during chronic inflammatory pain in mice

Effects of Carbon Monoxide Releasing Molecule-Liberated CO on Severe Acute Pancreatitis in Rats

Spinal Heme Oxygenase-1 (HO-1) Exerts Antinociceptive Effects Against Neuropathic Pain in a Mouse Model of L5 Spinal Nerve Ligation

Ozone promotes macrophage efferocytosis and alleviates neuropathic pain by activating the AMPK/Gas6-MerTK/SOCS3 signaling pathway

Sulforaphane Inhibited the Nociceptive Responses, Anxiety- and Depressive-Like Behaviors Associated With Neuropathic Pain and Improved the Anti-allodynic Effects of Morphine in Mice

Obacunone Alleviates Inflammatory Pain by Promoting M2 Microglial Polarization and by Activating Nrf2/HO-1 Signaling Pathway

Cannabinoid Receptor Agonist WIN55,212-2 and Fatty Acid Amide Hydrolase Inhibitor URB597 Ameliorate Neuroinflammatory Responses in Chronic Cerebral Hypoperfusion Model by Blocking NF-κB Pathways

Effect and Mechanism of Inhibition of PI3K/Akt/mTOR Signal Pathway on Chronic Neuropathic Pain and Spinal Microglia in a Rat Model of Chronic Constriction Injury.